1. WideraEW SmithAK. Aducanumab (Aduhelm) for the treatment of Alzheimers: A podcast with Aaron Kesselheim and Jason Karlawish. July 29 2021. Accessed October 4 2021.https://www.geripal.org/2021/07/blog-post.html
2. CovinskyK SmithAK WideraEW. American Geriatrics Society Annual Meeting: 2021 Geriatrics Literature Update. Accessed October 4 2021.https://geriatricscareonline.org/ProductAbstract/2021-Geriatrics-Literature-Update/M0021
3. American Geriatrics Society. Letter on Food and Drug Administration's Review of Biogen's drug Aducanumab for Alzheimer's disease. June 2 2021. Accessed October 5 2021.https://www.americangeriatrics.org/sites/default/files/inline-files/American%20Geriatrics%20Society_Letter%20to%20FDA%20Biogen%20Drug%20for%20Alzheimer%27s%20%28June%202021%29%20FINAL%20%281%29.pdf
4. American Academy of Neurology American Geriatrics Society Society of Nuclear Medicine and Molecular Imaging. Joint Letter to Centers for Medicare & Medicaid Services on Beta Amyloid PET Coverage. July 19 2021. Accessed October 5 2021.https://www.americangeriatrics.org/sites/default/files/inline-files/CMS%20Letter%20on%20Beta%20Amyloid%20PET%20coverage%20071921%20-%20FINAL_0.pdf
5. American Geriatrics Society. Aducanumab: What Clinicians Should Know. July 15 2021. Accessed October 5 2021.https://geriatricscareonline.org/ProductAbstract/Aducanumab-What-Clinicians-Should-Know/PC0013